Citations (109)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (13)
Giuseppe Rinonapoli, Stefano Coaccioli & Lorenzo Panella. (2019) Tapentadol in the treatment of osteoarthritis: pharmacological rationale and clinical evidence. Journal of Pain Research 12, pages 1529-1536.
Read now
Read now
Ramani Vijayan, Gauhar Afshan, Khalid Bashir, Mary Cardosa, Madhur Chadha, Pongparadee Chaudakshetrin, Khin Myo Hla, Muralidhar Joshi, Francis O Javier, Asif Gul Kayani, Andi Takdir Musba, Sasikaan Nimmaanrat, Dwi Pantjawibowo, Jocelyn C Que & Palanisamy Vijayanand. (2018) Tramadol: a valuable treatment for pain in Southeast Asian countries. Journal of Pain Research 11, pages 2567-2575.
Read now
Read now
Joseph V. Pergolizzi$suffix/text()$suffix/text(), Jo Ann LeQuang, Robert Taylor$suffix/text()$suffix/text(), Michael H. Ossipov, Daniel Colucci & Robert B. Raffa. (2018) Designing safer analgesics: a focus on μ-opioid receptor pathways. Expert Opinion on Drug Discovery 13:10, pages 965-972.
Read now
Read now
Laura E. Gressler, Drayton A. Hammond & Jacob T. Painter. (2017) Serotonin Syndrome in Tapentadol Literature: Systematic Review of Original Research. Journal of Pain & Palliative Care Pharmacotherapy 31:3-4, pages 228-236.
Read now
Read now
Bill McCarberg, Yvonne D’Arcy, Bruce Parsons, Alesia Sadosky, Andrew Thorpe & Regina Behar. (2017) Neuropathic pain: a narrative review of etiology, assessment, diagnosis, and treatment for primary care providers. Current Medical Research and Opinion 33:8, pages 1361-1369.
Read now
Read now
Jeffrey Fudin, Timothy J Atkinson, Mena Raouf & Michael E Schatman. (2016) Can we not work together to help family practitioners become more effective pain managers?. Journal of Pain Research 9, pages 803-806.
Read now
Read now
Joana Barbosa, Juliana Faria, Odília Queirós, Roxana Moreira, Félix Carvalho & Ricardo Jorge Dinis-Oliveira. (2016) Comparative metabolism of tramadol and tapentadol: a toxicological perspective. Drug Metabolism Reviews 48:4, pages 577-592.
Read now
Read now
Nalini Vadivelu, Alice Kai, Benjamin Maslin, Gopal Kodumudi, Aron Legler & Jack M Berger. (2015) Tapentadol extended release in the management of peripheral diabetic neuropathic pain. Therapeutics and Clinical Risk Management 11, pages 95-105.
Read now
Read now
Maree T Smith & Arjun Muralidharan. (2015) Targeting angiotensin II type 2 receptor pathways to treat neuropathic pain and inflammatory pain. Expert Opinion on Therapeutic Targets 19:1, pages 25-35.
Read now
Read now
Casilda M. Balmaceda. (2015) The impact of ethnicity and cardiovascular risk on the pharmacologic management of osteoarthritis: a US perspective. Postgraduate Medicine 127:1, pages 51-56.
Read now
Read now
Howard S. Smith, Robert B. Raffa, Joseph V. Pergolizzi, Robert Taylor & Ronald J. Tallarida. (2014) Combining Opioid and Adrenergic Mechanisms for Chronic Pain. Postgraduate Medicine 126:4, pages 98-114.
Read now
Read now
Joseph V. Pergolizzi$suffix/text()$suffix/text(), Marco Pappagallo, JoAnn LeQuang, Sumedha Labhsetwar & Robert Taylor$suffix/text()$suffix/text(). (2014) New Health Care Measures: Emphasis on Better Management of Postsurgical Pain and Postoperative Nausea and Vomiting. Hospital Practice 42:1, pages 65-74.
Read now
Read now
Nalini Vadivelu, Yili Huang, Brian Mirante, Michael Jacoby, Ferne R Braveman, Roberta L Hines & Raymond Sinatra. (2013) Patient considerations in the use of tapentadol for moderate to severe pain. Drug, Healthcare and Patient Safety 5, pages 151-159.
Read now
Read now
Articles from other publishers (96)
J. Barakji, S. K. Korang, J. B. Feinberg, M. Maagaard, O. Mathiesen, C. Gluud & J. C. Jakobsen. (2023) Tramadol for chronic pain in adults: protocol for a systematic review with meta-analysis and trial sequential analysis of randomised clinical trials. Systematic Reviews 12:1.
Crossref
Crossref
Joana Barbosa, Sandra Leal, Frederico C. Pereira, Ricardo Jorge Dinis-Oliveira & Juliana Faria. (2023) Tramadol and Tapentadol Induce Conditioned Place Preference with a Differential Impact on Rewarding Memory and Incubation of Craving. Pharmaceuticals 16:1, pages 86.
Crossref
Crossref
Joseph Pergolizzi, Giustino Varrassi, Jo Ann K LeQuang, Frank Breve & Peter Magnusson. (2023) Fixed Dose Versus Loose Dose: Analgesic Combinations. Cureus.
Crossref
Crossref
Suzanne K Vosburg, Taryn Dailey-Govoni, Jared Beaumont, Stephen F Butler & Jody L Green. (2022) Characterizing the Experience of Tapentadol Nonmedical Use: Mixed Methods Study. JMIR Formative Research 6:6, pages e16996.
Crossref
Crossref
Peng Xie, Junjie Zhang, Baiyu Chen, Xinwei Li, Wenbo Zhang, Mengdan Zhu, Wei Li, Jianqi Li & Wei Fu. (2022) Computational Methods for Understanding the Selectivity and Signal Transduction Mechanism of Aminomethyl Tetrahydronaphthalene to Opioid Receptors. Molecules 27:7, pages 2173.
Crossref
Crossref
Silvia L. Cruz, Miguel I. Paz-Ramos, Araceli Hernández-Mendoza & César J. Carranza-Aguilar. 2022. Opioids. Opioids
149
174
.
Tao Long, Rodrigo Cristofoletti, Brian Cicali, Veronique Michaud, Pamela Dow, Jacques Turgeon & Stephan Schmidt. (2021) Physiologically Based Pharmacokinetic Modeling to Assess the Impact of CYP2D6‐Mediated Drug‐Drug Interactions on Tramadol and O‐Desmethyltramadol Exposures via Allosteric and Competitive Inhibition. The Journal of Clinical Pharmacology 62:1, pages 76-86.
Crossref
Crossref
Farhad Gholami, Mahdieh Sadeghi, Zakaria Zakariaei, Mostafa Soleymani & Abdollah Malakian. (2022) Rhabdomyolysis and acute kidney injury due to suicide attempt with tramadol: A rare case report. Clinical Case Reports 10:1.
Crossref
Crossref
Anshit GoyalStephanie Payne, Lindsey R. Sangaralingham, Molly Moore Jeffery, James M. Naessens, Halena M. Gazelka, Elizabeth B. Habermann, William KraussRobert J. SpinnerMohamad Bydon. (2021) Incidence and risk factors for prolonged postoperative opioid use following lumbar spine surgery: a cohort study. Journal of Neurosurgery: Spine 35:5, pages 583-591.
Crossref
Crossref
Iqira Saeed, Adam La Caze, Markus W. Hollmann, Paul N. Shaw & Marie-Odile Parat. (2021) New Insights on Tramadol and Immunomodulation. Current Oncology Reports 23:11.
Crossref
Crossref
Stella Iacovides, Peter Kamerman, Fiona C Baker & Duncan Mitchell. 2011. Comprehensive Physiology. Comprehensive Physiology
2589
2619
.
Brian A. Baldo. (2021) Toxicities of opioid analgesics: respiratory depression, histamine release, hemodynamic changes, hypersensitivity, serotonin toxicity. Archives of Toxicology 95:8, pages 2627-2642.
Crossref
Crossref
Lucien Roulet, Victoria Rollason, Jules Desmeules & Valérie Piguet. (2021) Tapentadol Versus Tramadol: A Narrative and Comparative Review of Their Pharmacological, Efficacy and Safety Profiles in Adult Patients. Drugs 81:11, pages 1257-1272.
Crossref
Crossref
Samaneh Nakhaee, Christopher Hoyte, Richard C. Dart, Masoumeh Askari, Roland J. Lamarine & Omid Mehrpour. (2021) A review on tramadol toxicity: mechanism of action, clinical presentation, and treatment. Forensic Toxicology 39:2, pages 293-310.
Crossref
Crossref
Szabolcs Koncz, Noémi Papp, Noémi Menczelesz, Dóra Pothorszki & György Bagdy. (2021) EEG and Sleep Effects of Tramadol Suggest Potential Antidepressant Effects with Different Mechanisms of Action. Pharmaceuticals 14:5, pages 431.
Crossref
Crossref
Claire de Canecaude, Vanessa Rousseau, Leila Chebane, Margaux Lafaurie, Geneviève Durrieu & Jean‐Louis Montastruc. (2020) Can tramadol really induce hyponatraemia? A pharmacovigilance study. British Journal of Clinical Pharmacology 87:2, pages 683-686.
Crossref
Crossref
Joana Barbosa, Juliana Faria, Fernanda Garcez, Sandra Leal, Luís Pedro Afonso, Ana Vanessa Nascimento, Roxana Moreira, Frederico C. Pereira, Odília Queirós, Félix Carvalho & Ricardo Jorge Dinis-Oliveira. (2021) Repeated Administration of Clinically Relevant Doses of the Prescription Opioids Tramadol and Tapentadol Causes Lung, Cardiac, and Brain Toxicity in Wistar Rats. Pharmaceuticals 14:2, pages 97.
Crossref
Crossref
Emma Guymer & Geoffrey Littlejohn. 2021. Fibromyalgia Syndrome. Fibromyalgia Syndrome
33
52
.
Brian A. Baldo & Nghia H. PhamBrian A. Baldo & Nghia H. Pham. 2021. Drug Allergy. Drug Allergy
411
438
.
Flaminia Coluzzi & Sebastiano Mercadante. (2020) The Potential Role of Dual Mechanistic Opioids in Combating Opioid Misuse. Current Anesthesiology Reports 10:4, pages 416-422.
Crossref
Crossref
Jean-Louis Montastruc, Vanessa Rousseau, Claire de Canecaude, Anne Roussin & François Montastruc. (2020) Role of serotonin and norepinephrine transporters in antidepressant-induced arterial hypertension: a pharmacoepidemiological-pharmacodynamic study. European Journal of Clinical Pharmacology 76:9, pages 1321-1327.
Crossref
Crossref
Joana Barbosa, Juliana Faria, Fernanda Garcez, Sandra Leal, Luís Pedro Afonso, Ana Vanessa Nascimento, Roxana Moreira, Odília Queirós, Félix Carvalho & Ricardo Jorge Dinis-Oliveira. (2020) Repeated Administration of Clinical Doses of Tramadol and Tapentadol Causes Hepato- and Nephrotoxic Effects in Wistar Rats. Pharmaceuticals 13:7, pages 149.
Crossref
Crossref
. (2020) Manage perioperative pain in morbidly obese patients by taking an all-round multimodal approach. Drugs & Therapy Perspectives 36:4, pages 139-145.
Crossref
Crossref
Brian A. Baldo & Michael A. Rose. (2020) The anaesthetist, opioid analgesic drugs, and serotonin toxicity: a mechanistic and clinical review. British Journal of Anaesthesia 124:1, pages 44-62.
Crossref
Crossref
John A. Zebala, Shawn L. Searle, Lynn R. Webster, Matt S. Johnson, Aaron D. Schuler, Dean Y. Maeda & Stuart J. Kahn. (2019) Desmetramadol Has the Safety and Analgesic Profile of Tramadol Without Its Metabolic Liabilities: Consecutive Randomized, Double-Blind, Placebo- and Active Comparator-Controlled Trials. The Journal of Pain 20:10, pages 1218-1235.
Crossref
Crossref
Eleftheria Soulioti, Athanasia Tsaroucha, Alexandros Makris, Maria Koutsaki, Eirini Sklika, Argyro Mela, Panayiotis D. Megaloikonomos, Andreas F. Mavrogenis & Argyro Fassoulaki. (2019) Addition of 100 mg of Tramadol to 40 mL of 0.5% Ropivacaine for Interscalene Brachial Plexus Block Improves Postoperative Analgesia in Patients Undergoing Shoulder Surgeries as Compared to Ropivacaine Alone—A Randomized Controlled Study. Medicina 55:7, pages 399.
Crossref
Crossref
Imane Belcaid & Naveen Eipe. (2019) Perioperative Pain Management in Morbid Obesity. Drugs 79:11, pages 1163-1175.
Crossref
Crossref
Sohyun Jeong, Ha Jin Tchoe, Junqing Li & Ju-Young Shin. (2019) All-Cause Mortality Associated with Tramadol Use: A Case-Crossover Study. Drug Safety 42:6, pages 785-796.
Crossref
Crossref
. 2019. Demystifying Drug Dosing in Renal Dysfunction. Demystifying Drug Dosing in Renal Dysfunction
189
200
.
Cornelius A Thiels, Elizabeth B Habermann, W Michael Hooten & Molly M Jeffery. (2019) Chronic use of tramadol after acute pain episode: cohort study. BMJ, pages l1849.
Crossref
Crossref
Pablo Gaztañaga, Ricardo Baggio, Emilia Halac & Daniel R. Vega. (2019) Thermal, spectroscopic and structural analysis of a thermosalient phase transformation in tapentadol hydrochloride. Acta Crystallographica Section B Structural Science, Crystal Engineering and Materials 75:2, pages 183-191.
Crossref
Crossref
Nicholas Fuggle, Elizabeth Curtis, Sarah Shaw, Laura Spooner, Olivier Bruyère, Georgia Ntani, Camille Parsons, Philip G. Conaghan, Nadia Corp, Germain Honvo, Daniel Uebelhart, Janis Baird, Elaine Dennison, Jean-Yves Reginster & Cyrus Cooper. (2019) Safety of Opioids in Osteoarthritis: Outcomes of a Systematic Review and Meta-Analysis. Drugs & Aging 36:S1, pages 129-143.
Crossref
Crossref
Masayuki Kaneshima & Kinomi Yomiya. (2019) A Case of Serotonin Syndrome Caused by Combination Therapy with Tapentadol and a Selective Serotonin Reuptake Inhibitorタペンタドールと選択的セロトニン再取り込み阻害薬の併用でセロトニン症候群を発症した1例. Palliative Care Research 14:3, pages 203-207.
Crossref
Crossref
Francesca F. Caputi, Mariaflavia Nicora, Roberto Simeone, Sanzio Candeletti & Patrizia Romualdi. (2019) Tapentadol: an analgesic that differs from classic opioids due to its noradrenergic mechanism of action. Minerva Medica 110:1.
Crossref
Crossref
Parnika P. Saxena & J. Alexander Bodkin. (2018) Opioidergic Agents as Antidepressants: Rationale and Promise. CNS Drugs 33:1, pages 9-16.
Crossref
Crossref
Jonathan Silverman & Amitabh Gulati. 2019. Academic Pain Medicine. Academic Pain Medicine
177
210
.
Robert B. Raffa, Christian Elling & Thomas M. Tzschentke. (2018) Does ‘Strong Analgesic’ Equal ‘Strong Opioid’? Tapentadol and the Concept of ‘µ-Load’. Advances in Therapy 35:10, pages 1471-1484.
Crossref
Crossref
Jessie S Channell & Stephan Schug. (2018) Toxicity of tapentadol: a systematic review. Pain Management 8:5, pages 327-339.
Crossref
Crossref
C.A. Bradbrook & L. Clark. (2018) State of the art analgesia- recent developments in pharmacological approaches to acute pain management in dogs and cats. Part 1. The Veterinary Journal 238, pages 76-82.
Crossref
Crossref
Brian A. Baldo. (2018) Opioid analgesic drugs and serotonin toxicity (syndrome): mechanisms, animal models, and links to clinical effects. Archives of Toxicology 92:8, pages 2457-2473.
Crossref
Crossref
R. B. Raffa, J. V. Pergolizzi, R. Taylor & M. H. Ossipov. (2018) Nature's first “atypical opioids”: Kratom and mitragynines. Journal of Clinical Pharmacy and Therapeutics 43:3, pages 437-441.
Crossref
Crossref
Joseph V. PergolizziJrJr, Robert TaylorJrJr, Jo Ann LeQuang, Robert B. Raffa & John Bisney. (2018) Tapentadol Extended Release in the Treatment of Severe Chronic Low Back Pain and Osteoarthritis Pain. Pain and Therapy 7:1, pages 37-57.
Crossref
Crossref
J. Faria, J. Barbosa, R. Moreira, O. Queirós, F. Carvalho & R.J. Dinis-Oliveira. (2018) Comparative pharmacology and toxicology of tramadol and tapentadol. European Journal of Pain 22:5, pages 827-844.
Crossref
Crossref
Carmen Abeyaratne, Samanta Lalic, J. Simon Bell & Jenni Ilomäki. (2018) Spontaneously reported adverse drug events related to tapentadol and oxycodone/naloxone in Australia. Therapeutic Advances in Drug Safety 9:4, pages 197-205.
Crossref
Crossref
Suzanne K. Vosburg, S. Geoffrey Severtson, Richard C. Dart, Theodore J. Cicero, Steven P. Kurtz, Mark W. Parrino & Jody L. Green. (2018) Assessment of Tapentadol API Abuse Liability With the Researched Abuse, Diversion and Addiction-Related Surveillance System. The Journal of Pain 19:4, pages 439-453.
Crossref
Crossref
Thien C. Pham, Courtney Kominek, Abigail Brooks & Jeffrey Fudin. 2018. The American Society of Addiction Medicine Handbook on Pain and Addiction. The American Society of Addiction Medicine Handbook on Pain and Addiction
163
173
.
Mark Holtsman & Charity Hale. 2018. Essentials of Pain Medicine. Essentials of Pain Medicine
385
388.e1
.
Heath B. McAnallyHeath B. McAnally. 2018. Opioid Dependence. Opioid Dependence
73
97
.
M. Raouf, A. J. Glogowski, J. J. Bettinger & J. Fudin. (2017) Serotonin-norepinephrine reuptake inhibitors and the influence of binding affinity (Ki) on analgesia. Journal of Clinical Pharmacy and Therapeutics 42:4, pages 513-517.
Crossref
Crossref
Joana Barbosa, Juliana Faria, Sandra Leal, Luís Pedro Afonso, João Lobo, Odília Queirós, Roxana Moreira, Félix Carvalho & Ricardo Jorge Dinis-Oliveira. (2017) Acute administration of tramadol and tapentadol at effective analgesic and maximum tolerated doses causes hepato- and nephrotoxic effects in Wistar rats. Toxicology 389, pages 118-129.
Crossref
Crossref
Joseph V PergolizziJrJr, Frank Breve, Robert TaylorJrJr, Robert B Raffa, Stephani E Strasburger & Jo Ann LeQuang. (2017) Considering tapentadol as a first-line analgesic: 14 questions. Pain Management 7:4, pages 331-339.
Crossref
Crossref
Juliana Faria, Joana Barbosa, Sandra Leal, Luís Pedro Afonso, João Lobo, Roxana Moreira, Odília Queirós, Félix Carvalho & Ricardo Jorge Dinis-Oliveira. (2017) Effective analgesic doses of tramadol or tapentadol induce brain, lung and heart toxicity in Wistar rats. Toxicology 385, pages 38-47.
Crossref
Crossref
Joseph V. PergolizziJr.Jr., Jo Ann LeQuang, Garrett K. Berger & Robert B. Raffa. (2017) The Basic Pharmacology of Opioids Informs the Opioid Discourse about Misuse and Abuse: A Review. Pain and Therapy 6:1, pages 1-16.
Crossref
Crossref
Marc RussoDanielle SantarelliGeoff Isbister. (2017) Comment on “Probable Tapentadol-Associated Serotonin Syndrome after Overdose”. Hospital Pharmacy 52:4, pages 248-248.
Crossref
Crossref
R. B. Raffa, G. Burdge, J. Gambrah, H. E. Kinecki, F. Lin, B. Lu, J. T. Nguyen, V. Phan, A. Ruan, M. A. Sesay & T. N. Watkins. (2017) Cebranopadol: novel dual opioid/NOP receptor agonist analgesic. Journal of Clinical Pharmacy and Therapeutics 42:1, pages 8-17.
Crossref
Crossref
Weiyang Christopher Liu, Zhong Xi Zheng, Kian Hian Tan & Gregory J. Meredith. (2017) Multidimensional Treatment of Cancer Pain. Current Oncology Reports 19:2.
Crossref
Crossref
Shereen Abdelhakim Abdelaleem, Osama A. Hassan, Rasha F. Ahmed, Nagwa M. Zenhom, Rehab A. Rifaai & Nashwa F. El-Tahawy. (2017) Tramadol Induced Adrenal Insufficiency: Histological, Immunohistochemical, Ultrastructural, and Biochemical Genetic Experimental Study. Journal of Toxicology 2017, pages 1-14.
Crossref
Crossref
Samuel Hardy, Mark Angelo, Krista Haas, Huda Sayed & Vincent J. Vanston. 2017. Urogenital Pain. Urogenital Pain
157
175
.
Peter Keogh & Vivek Mehta. (2016) Recent Advances in the Pharmacological Management of Neuropathic Pain. Current Anesthesiology Reports 6:4, pages 327-333.
Crossref
Crossref
Joel Wann Ee Chin & Kamen Valchanov. (2016) Pharmacological Management of Post-thoracotomy Pain. Open Medicine Journal 3:1, pages 255-264.
Crossref
Crossref
Richard M Langford, Roger Knaggs, Paul Farquhar-Smith & Anthony H Dickenson. (2016) Is tapentadol different from classical opioids? A review of the evidence. British Journal of Pain 10:4, pages 217-221.
Crossref
Crossref
Camille Lagard, Lucie Chevillard, Isabelle Malissin, Patricia Risède, Jacques Callebert, Laurence Labat, Jean-Marie Launay, Jean-Louis Laplanche & Bruno Mégarbane. (2016) Mechanisms of tramadol-related neurotoxicity in the rat: Does diazepam/tramadol combination play a worsening role in overdose?. Toxicology and Applied Pharmacology 310, pages 108-119.
Crossref
Crossref
Joseph V. PergolizziJrJr, Robert B. Raffa, Gianpietro Zampogna, Frank Breve, Robert Colucci, William K. Schmidt & Jo Ann LeQuang. (2016)
Comments and Suggestions from Pain Specialists Regarding the
CDC
's Proposed Opioid Guidelines
. Pain Practice 16:7, pages 794-808.
Crossref
Crossref
Geoffrey O Littlejohn, Emma K Guymer & Gene-Siew Ngian. (2016) Is there a role for opioids in the treatment of fibromyalgia?. Pain Management 6:4, pages 347-355.
Crossref
Crossref
Juliana Faria, Joana Barbosa, Odília Queirós, Roxana Moreira, Félix Carvalho & Ricardo Jorge Dinis-Oliveira. (2016) Comparative study of the neurotoxicological effects of tramadol and tapentadol in SH-SY5Y cells. Toxicology 359-360, pages 1-10.
Crossref
Crossref
I. Capik, O. Nagy, C. Tothova & I. Polkowska. (2016) Comparison of tramadol and buprenorphine analgesia for continuous intravenous propofol anaesthesia in dogs undergoing dental prophylaxis. Veterinární medicína 61:4, pages 213-218.
Crossref
Crossref
Milena De Felice & Michael H Ossipov. (2016) Cortical and subcortical modulation of pain. Pain Management 6:2, pages 111-120.
Crossref
Crossref
Andrea Wolkerstorfer, Norbert Handler & Helmut Buschmann. (2016) New approaches to treating pain. Bioorganic & Medicinal Chemistry Letters 26:4, pages 1103-1119.
Crossref
Crossref
Hikaru Sada, Makoto Kajizono, Yoshihisa Kitamura & Toshiaki Sendo. (2016) Drug interaction (35. Opioid-analgesic drug interactions). Okayama Igakkai Zasshi (Journal of Okayama Medical Association) 128:1, pages 53-59.
Crossref
Crossref
Ben T. Tsutaoka, Raymond Y. Ho, Stacey M. Fung & Thomas E. Kearney. (2015) Comparative Toxicity of Tapentadol and Tramadol Utilizing Data Reported to the National Poison Data System. Annals of Pharmacotherapy 49:12, pages 1311-1316.
Crossref
Crossref
Pankaj J. Pasricha. 2015. Yamada' s Textbook of Gastroenterology. Yamada' s Textbook of Gastroenterology
695
722
.
Felicity C. Veal & Gregory M. Peterson. (2015) Pain in the Frail or Elderly Patient: Does Tapentadol Have a Role?. Drugs & Aging 32:6, pages 419-426.
Crossref
Crossref
Boaz G. Samolsky Dekel, Sivia Ghedini, Alberto Gori, Alessio Vasarri, GianFranco Di Nino & Rita M. Melotti. (2015) Lasting Prolonged-Release Tapentadol for Moderate/Severe Non-Cancer Musculoskeletal Chronic Pain. Pain and Therapy 4:1, pages 107-117.
Crossref
Crossref
Carolyn M. McKune, Joanna C. Murrell, Andrea M. Nolan, Kate L. White & Bonnie D. Wright. 2015. Veterinary Anesthesia and Analgesia. Veterinary Anesthesia and Analgesia
584
623
.
Daniel S. J. Pang. 2015. Veterinary Anesthesia and Analgesia. Veterinary Anesthesia and Analgesia
244
259
.
Casandra J Rosenberg & James C Watson. (2015) Treatment of painful diabetic peripheral neuropathy. Prosthetics & Orthotics International 39:1, pages 17-28.
Crossref
Crossref
Hyung Gon Lee, Woong Mo Kim, Joung Min Kim, Hong-Beom Bae & Jeong Il Choi. (2015) Intrathecal nefopam-induced antinociception through activation of descending serotonergic projections involving spinal 5-HT7 but not 5-HT3 receptors. Neuroscience Letters 587, pages 120-125.
Crossref
Crossref
Stephen F. Butler, Emily C. McNaughton & Ryan A. Black. (2015) Tapentadol Abuse Potential: A Postmarketing Evaluation Using a Sample of Individuals Evaluated for Substance Abuse Treatment. Pain Medicine 16:1, pages 119-130.
Crossref
Crossref
Marni G. Hillinger & Ellen W. K. Rosenquist. 2015. Fibromyalgia. Fibromyalgia
165
174
.
Donald R TaylorDonald R Taylor. 2015. Managing Patients with Chronic Pain and Opioid Addiction. Managing Patients with Chronic Pain and Opioid Addiction
3
17
.
Robert Raffa, Jaclyn Beckett, Vivek Brahmbhatt, Theresa Ebinger, Chrisjon Fabian, Justin Nixon, Steven Orlando, Chintan Rana, Ali Tejani & Robert Tomazic. 2014. Kratom and Other Mitragynines. Kratom and Other Mitragynines
9
22
.
David BorsookRichard HargreavesChas BountraFrank Porreca. (2014) Lost but making progress—Where will new analgesic drugs come from?. Science Translational Medicine 6:249.
Crossref
Crossref
Francesca Felicia Caputi, Donatella Carretta, Thomas M. Tzschentke, Sanzio Candeletti & Patrizia Romualdi. (2014) Opioid Receptor Gene Expression in Human Neuroblastoma SH-SY5Y Cells Following Tapentadol Exposure. Journal of Molecular Neuroscience 53:4, pages 669-676.
Crossref
Crossref
Grisell Vargas-Schaffer. (2014) Drugs able to prevent chronic pain. Techniques in Regional Anesthesia and Pain Management 18:3, pages 92-99.
Crossref
Crossref
Mariangela Lopopolo, Giannapia Affaitati, Alessandra Fabrizio, Francesca Massimini, Domenico Lapenna, Maria Adele Giamberardino & Raffaele Costantini. (2014) Effects of tramadol on viscero-visceral hyperalgesia in a rat model of endometriosis plus ureteral calculosis. Fundamental & Clinical Pharmacology 28:3, pages 331-341.
Crossref
Crossref
Michael H. Ossipov, Kozo Morimura & Frank Porreca. (2014) Descending pain modulation and chronification of pain. Current Opinion in Supportive & Palliative Care 8:2, pages 143-151.
Crossref
Crossref
Thomas M. Tzschentke, Thomas Christoph & Babette Y. Kögel. (2014) The Mu-Opioid Receptor Agonist/Noradrenaline Reuptake Inhibition (MOR–NRI) Concept in Analgesia: The Case of Tapentadol. CNS Drugs 28:4, pages 319-329.
Crossref
Crossref
Diana S. Meske, Jennifer Y. Xie, Janice Oyarzo, Hamid Badghisi, Michael H. Ossipov & Frank Porreca. (2014) Opioid and noradrenergic contributions of tapentadol in experimental neuropathic pain. Neuroscience Letters 562, pages 91-96.
Crossref
Crossref
Rasmus Steen Pedersen, Per Damkier, Mette Marie Hougaard Christensen & Kim Brosen. (2013) A cytochrome P450 phenotyping cocktail causing unexpected adverse reactions in female volunteers. European Journal of Clinical Pharmacology 69:12, pages 1997-1999.
Crossref
Crossref
Jae Hyup Lee & Chong-Suh Lee. (2013) A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of the Extended-Release Tramadol Hydrochloride/Acetaminophen Fixed-Dose Combination Tablet for the Treatment of Chronic Low Back Pain. Clinical Therapeutics 35:11, pages 1830-1840.
Crossref
Crossref
Judith P. Parker, Simone P. Javaher, Frank K. JacksonIVIV & Gregory T. Carter. (2013) Considerations for Neuropathic Pain Conditions in Life Care Planning. Physical Medicine and Rehabilitation Clinics of North America 24:3, pages 507-520.
Crossref
Crossref
William W. Stoops, Paul E. A. Glaser & Craig R. Rush. (2013) Miotic and subject-rated effects of therapeutic doses of tapentadol, tramadol, and hydromorphone in occasional opioid users. Psychopharmacology 228:2, pages 255-262.
Crossref
Crossref
Robert B. Raffa, Jaclyn R. Beckett, Vivek N. Brahmbhatt, Theresa M. Ebinger, Chrisjon A. Fabian, Justin R. Nixon, Steven T. Orlando, Chintan A. Rana, Ali H. Tejani & Robert J. Tomazic. (2013) Orally Active Opioid Compounds from a Non-Poppy Source. Journal of Medicinal Chemistry 56:12, pages 4840-4848.
Crossref
Crossref
Robert Taylor, Joseph V. Pergolizzi & Robert B. Raffa. (2013) Tapentadol Extended Release for Chronic Pain Patients. Advances in Therapy 30:1, pages 14-27.
Crossref
Crossref
Helmut Buschmann. 2012. Analogue‐Based Drug Discovery III. Analogue‐Based Drug Discovery III
295
318
.
Michael H. Ossipov. (2012) The Perception and Endogenous Modulation of Pain. Scientifica 2012, pages 1-25.
Crossref
Crossref